Published on
Dec 21, 2024
Machine Learning Model Accurately Predicts Long-Term HCC Risk in Patients with HBV
A novel machine learning model may offer a more accurate tool for forecasting de novo hepatocellular carcinoma (HCC) risk in virologically and biochemically stable patients with chronic hepatitis B virus (HBV) after 5 years of potent antiviral therapy.1 …
Source:
HCPLive
-
Label Pending
)
